Anti-TB Dosing for 60kg Adult with CNS Tuberculosis
For a 60kg adult with CNS tuberculosis, administer rifampicin 600mg, isoniazid 300mg, pyrazinamide 2.0g, and ethambutol 900mg (15mg/kg) daily for 2 months, followed by rifampicin 600mg and isoniazid 300mg daily for 10 additional months (total 12 months), plus adjunctive corticosteroids. 1, 2
Regimen Structure
Intensive Phase (2 months)
- Rifampicin: 600mg daily (10mg/kg, >50kg dose) 1
- Isoniazid: 300mg daily 1
- Pyrazinamide: 2.0g daily (>50kg dose, approximately 33mg/kg) 1
- Ethambutol: 900mg daily (15mg/kg) 1
Continuation Phase (10 months)
Critical CNS-Specific Considerations
CNS tuberculosis requires 12 months total treatment duration, not the standard 6 months used for pulmonary TB. 1, 2 This extended duration is essential because:
- Rifampicin penetrates the blood-brain barrier poorly 1, 3
- CNS disease requires prolonged therapy to prevent relapse 1, 2
- The continuation phase must extend to 10 months after the initial 2-month intensive phase 1, 2
Adjunctive Corticosteroids (Mandatory)
All patients with CNS TB should receive corticosteroids regardless of disease severity. 2 Options include:
- Dexamethasone (preferred in meningitis): Initial high dose (e.g., 12-16mg daily), tapering over several weeks 1
- Prednisolone: 60mg daily initially, tapering over several weeks 1
Weight-Based Dosing Nuances
For this 60kg patient (>50kg category):
- The British Thoracic Society guidelines clearly stratify dosing at the 50kg threshold 1
- Pyrazinamide increases from 1.5g (<50kg) to 2.0g (>50kg) 1
- Rifampicin increases from 450mg (<50kg) to 600mg (>50kg) 1
Important caveat: Recent evidence suggests patients in lower weight bands may achieve subtherapeutic concentrations with standard dosing 4, but at 60kg this patient is safely above the threshold where underdosing becomes problematic.
Drug Penetration into CNS
The four-drug regimen is chosen based on CNS penetration:
- Isoniazid: Excellent CSF penetration 1, 2
- Pyrazinamide: Excellent CSF penetration 1, 2
- Rifampicin: Poor CSF penetration (hence the need for prolonged therapy) 1, 3, 5
- Ethambutol: Adequate penetration only when meninges are inflamed 1
Common Pitfalls to Avoid
Do not use 6-month regimen: CNS TB is explicitly excluded from standard 6-month short-course therapy 1
Do not omit the fourth drug: While ethambutol can be omitted in low-risk pulmonary TB, CNS disease severity mandates four-drug initial therapy 1, 2
Do not delay corticosteroids: Start simultaneously with anti-TB drugs; delaying worsens outcomes 2
Monitor for paradoxical reactions: CNS TB commonly develops worsening inflammation despite appropriate treatment, requiring continued or intensified corticosteroids 6, 7
Monitoring Requirements
- Baseline liver function tests before starting treatment 1
- Visual acuity monitoring for ethambutol toxicity (though risk is low at 15mg/kg) 1
- Clinical response assessment at regular intervals
- Neurological monitoring for complications (hydrocephalus, stroke, cranial nerve palsies) 2, 7
Alternative Considerations
If drug resistance is suspected or confirmed, or if standard therapy fails, consider:
- Higher-dose rifampicin (up to 15mg/kg or higher) - though recent trials at 15mg/kg showed no survival benefit 3, 5
- Fluoroquinolones (levofloxacin or moxifloxacin) for better CNS penetration 3, 5
- Linezolid for drug-resistant cases with good CNS penetration 5
The evidence base strongly supports this 12-month, four-drug intensive regimen with corticosteroids as the standard of care for CNS tuberculosis 1, 2, 7.